Seroprevalence of Herpes Simplex Virus Type 2 Antibodies among HIV- Infected Individuals Attending Lautech Teaching Hospital, Ogbomoso, Oyo State

Olayinka Adenike Titilayo, Ogunniran J. Akinwumi, Akanbi A. Olusola, Olayinka O. Akintunde, Amoo-Adeboye Basirat Opemipo and Opaleye O. Oladele
Additional contact information
Olayinka Adenike Titilayo: Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology
Ogunniran J. Akinwumi: Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology
Akanbi A. Olusola: Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology
Olayinka O. Akintunde: Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology
Amoo-Adeboye Basirat Opemipo: Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology
Opaleye O. Oladele: Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology

International Journal of Research and Scientific Innovation, 2025, vol. 12, issue 15, 1369-1377

Abstract: Background: Herpes Simplex Virus type 2 (HSV-2) is an opportunistic infection of public health concern globally among people living with HIV (PLWHIV). This study focused on the prevalence of and risk factors for HSV among PLWHIV to help them live a healthier life. Methods: A cross-sectional study was conducted at the Retroviral Clinic of LAUTECH Teaching Hospital, Ogbomosho, between December 2021 and June 2022. A total of 208 consenting individuals were enrolled in the study. Type-specific anti-HSV-2 IgG and IgM antibodies were detected using ELISA. Risk factors and the prevalence of HSV type 2 were analyzed using SPSS version 23. Results: The prevalence rates of HSV-2 IgG among 104 PLWHIV and 104 non-HIV were 40.4% and 0%, respectively. The prevalence of HSV-2 IgM among 104 PLWHIV and 104 non-HIV was 7.7% and 4.8%, respectively. A significant HSV-2 prevalence (3.8%, P=0.049) was reported among those with one or more sexual partners. The percentages of females and males who were positive for HSV-2 IgG were 40.0% and 41.0%, respectively. Conclusion: HSV-2 infection remains a significant comorbidity among PLWHIV. Increased awareness, screening, and prevention efforts are essential to reduce the dual burden.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.rsisinternational.org/journals/ijrsi/d ... sue-15/1369-1377.pdf (application/pdf)
https://rsisinternational.org/journals/ijrsi/artic ... -ogbomoso-oyo-state/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bjc:journl:v:12:y:2025:i:15:p:1369-1377

Access Statistics for this article

International Journal of Research and Scientific Innovation is currently edited by Dr. Renu Malsaria

More articles in International Journal of Research and Scientific Innovation from International Journal of Research and Scientific Innovation (IJRSI)
Bibliographic data for series maintained by Dr. Renu Malsaria ().